Institutional investors hold a majority ownership of ABBV through the 70.70% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 1.6 Million shares of AbbVie
ASSENAGON ASSET MANAGEMENT SA (G... Bought 648.8 Thousand shares of AbbVie
LPL FINANCIAL LLC Bought 556.1 Thousand shares of AbbVie